Amyloid Beta – Biotherapy Target and Biotechnological Tool

Alzheimer’s disease is a progressive neurodegenerative disease characterized primarily by memory impairment and cognitive decline. As of 2020, an estimated 50 million people suffer from Alzheimer’s ...